鼻咽癌
医学
转录因子
癌症研究
STAT1
生物
肿瘤科
内科学
基因
遗传学
受体
放射治疗
作者
Jingang Ai,Guolin Tan,Tiansheng Wang,Wei Li,Ru Gao,Yexun Song,Shanshan Xiong,Qing Xiang
出处
期刊:Future Oncology
[Future Medicine]
日期:2020-12-02
卷期号:17 (1): 57-69
被引量:7
标识
DOI:10.2217/fon-2020-0618
摘要
Aim: To investigate the role of LINC01160 in nasopharyngeal carcinoma (NPC). Materials & methods: Using NPC cells CNE-2 and HNE-2 in vitro, we performed quantitative PCR to determine mRNA expression and western blotting to determine protein expression. CCK-8, transwell, flow cytometry and wound healing assays were done to examine the function of LINC01160 and STAT1. Chromatin immunoprecipitation PCR (ChIP-PCR) confirmed that STAT1 combines with the LINC01160 promoter region. Xenograft experiments were used to verify the role of STAT1 and LINC01160 in vivo. Results: LINC01160 is upregulated in NPC and can promote a malignant cell phenotype. STAT1 is a transcription factor of LINC01160 and can promote a malignant cell phenotype through upregulating LINC01160 expression. Conclusion: STAT1 can promote a malignant cell phenotype by upregulating LINC01160.
科研通智能强力驱动
Strongly Powered by AbleSci AI